Related Experiment Videos
Recurrent group B streptococcal infections: Report of three cases
Insights
Recurrent group B streptococcus infections in infants are rare but occurred in three infants despite standard benzylpenicillin treatment. This suggests current therapies may be insufficient for some group B streptococcus (GBS) cases.
Area of Science:
- Neonatal infectious diseases
- Bacterial pathogenesis
- Clinical microbiology
Background:
- Group B Streptococcus (GBS) is a primary cause of neonatal infections.
- While GBS incidence is rising, patient recurrence is exceptionally rare.
- Standard treatment involves a minimum of 10 days of benzylpenicillin.
Observation:
- This report details three infants diagnosed with recurrent GBS disease.
- All infants received standard benzylpenicillin therapy.
- Following a symptom-free period, all three infants experienced disease recurrence.
Findings:
- The recurrence in these infants poses challenges in distinguishing between relapse and reinfection.
- Antibiotic sensitivity studies and immune responses are considered.
- The observed recurrences challenge the adequacy of current GBS treatment protocols.
Implications:
- Recurrent GBS infections may necessitate revised treatment strategies.
- Further research into GBS epidemiology and host immunity is crucial.
- Novel approaches for GBS prevention and treatment are warranted.
Abstract:
The group B streptococcus has become a leading cause of neonatal infection. Despite the increasing incidence of this infection, recurrence in the same patient is extremely uncommon. This report describes three infants with proved recurrent group B streptococcal disease. All patients were treated with benzylpenicillin for at least 10 days, but, after a symptom-free interval, each developed symptoms again. Whether the illness in these patients represents a relapse or a true reinfection is difficult to determine. Various possibilities are discussed. The development of a recurrent infection indicates that presently recommended therapy may be inadequate in certain instances. Comments about epidemiology, clinical picture, antibiotic sensitivity studies, and immunity are made along with speculations about possible approaches to treatment and prevention of this infection.